Peter Vozzo | ICR Westwicke, Investor Relations |
Jack Khattar | Chief Executive Officer |
Tim Dec | Chief Financial Officer |
David Amsellem | Piper Sandler |
Jack Padovano | Stifel |
Good afternoon and welcome to Supernus Pharmaceuticals' Third Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] As a reminder, this conference call is being recorded. I would now like to turn the conference over to Peter Vozzo of ICR Westwicke, Investor Relations representative for Supernus Pharmaceuticals. Sir, you may begin.